Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AST Revolution, LLC Launches Following Acquisition of Accelerate Diagnostics Assets
-
Mastercard Board of Directors Announces Quarterly Dividend
-
New Fortress Energy Reaches Milestone Agreement for Long-Term Gas Supply with Puerto Rican Government
-
MILLER INDUSTRIES TO HOST 1X1 INVESTOR MEETINGS AT THE 24TH ANNUAL D.A. DAVIDSON DIVERSIFIED INDUSTRIALS & SERVICES CONFERENCE ON SEPTEMBER 18TH IN NASHVILLE, TN
-
AGI Announces Q3 2025 Dividend
-
TCW Strategic Income Fund Announces Quarterly Distribution
-
Paychex, Inc. Schedules First Quarter Fiscal 2026 Earnings Conference Call for September 30, 2025
-
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
-
Lightwave Logic, Inc. Provides Update on its Executive Leadership Team
-
JD Bancshares, Inc. and JD Bank Appoint Carrie H. Calvin, CPA, CFE, and Preston Castille to Board of Directors
-
Greystone Housing Impact Investors LP Announces Regular Quarterly Cash Distribution
-
First Internet Bancorp to Pay Cash Dividend
-
Oatly Announces Pricing of Nordic Bonds, Which Are to be Used to Prepay Term Loan B and Repurchase and Cancel Certain U.S. Convertible Notes
-
REMAX NATIONAL HOUSING REPORT FOR AUGUST 2025
-
Himplant Launches "Himplant POV" AI Penile Enhancement Simulator
-
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
-
Rexford Industrial Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
-
Astronics Corporation Announces Closing of $225 Million of 0% Convertible Notes Offering
-
Chimera Investment Corporation Announces Closing of Public Offering of $120 Million Senior Notes
-
SEC to Host Webinar for Large Firms on Regulation S-P
-
IR-MED Investor Update Letter - Sept-2025
-
Flux Power Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025
-
Cohu Secures Additional Neon Orders, Raises 2025 Forecasted HBM Revenue to $10-$11 million
-
Sidus Space Announces Closing of Public Offering
-
Heidrick & Struggles to Participate in William Blair's Inaugural Human Capital Services Virtual Conference
-
InvenTrust Properties Corp. Declares Third Quarter 2025 Cash Dividend
-
Reed’s Announces Closing of $5.0 Million Private Placement and Board Updates
-
Arrow Electronics Announces Leadership Change
-
Ramaco Announces Appointment of Mike Graney to Board of Directors
-
Kilroy Realty Declares Quarterly Dividend
-
Sabra Health Care REIT, Inc. to Host Jefferies and Attend Mizuho’s Virtual REIT Conference
-
Resources Connection to Participate in William Blair’s Inaugural Human Capital Services Virtual Conference
-
agilon health to Participate in the 2025 Jefferies Healthcare Services Conference
-
Penguin Solutions Announces Fourth Quarter and Full Year Fiscal 2025 Conference Call
-
Empire State Realty Trust Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
-
Espey Mfg. & Electronics Corp. reports fourth quarter and year-end results
-
Safe Bulkers, Inc. Announces Results of 2025 Annual Meeting of Stockholders
-
Coherent Announces High-Performance Wire Grid Polarizers for Isolators in Datacom Transceivers
-
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
-
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
-
Illinois American Water Announces 2025 “Water Keeps Life Flowing” Art Contest
-
Jorie to Reveal the Most Advanced Automation Ever Seen in Revenue Management at HLTH 2025
-
Return to Freedom Mourns Loss of 'Irreplaceable' Friend, Board Member Robert Redford
-
GoPivot Expands Financial Wellbeing Offerings with Addition of Gift of College® to Rewards Marketplace
-
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
-
Dollar Tree, Inc. to Host 2025 Investor Conference
-
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
-
FormFactor Announces Participation in 17th Annual CEO Investor Summit 2025
-
Kaixin Holdings Announces Annual General Meeting Results
